Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 9Observational 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Psoriasis 1Nutrition Disorders 1Insulin Resistance 1Inflammatory Bowel Diseases 1Gastroparesis 1Feeding and Eating Disorders 1Esophageal Neoplasms 1Dumping Syndrome 1

Interventions

Surveys and Questionnaires 529Blood Specimen Collection 406Surgical Procedures, Operative 151Radiotherapy 131Interviews as Topic 131Drug Therapy 123Observation 122Magnetic Resonance Spectroscopy 104Biopsy 103Specimen Handling 70Data Collection 70Neoadjuvant Therapy 65Immunohistochemistry 64Magnetic Resonance Imaging 61Immune Checkpoint Inhibitors 59Watchful Waiting 52Immunotherapy 51Bevacizumab 50Positron Emission Tomography Computed Tomography 46Ultrasonography 44Hematologic Tests 42Liquid Biopsy 41Tomography, X-Ray Computed 40Therapeutics 40Radiosurgery 40Colonoscopy 40pembrolizumab 37Hepatectomy 37Gene Expression Profiling 36High-Energy Shock Waves 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Observational × Sulfasalazine × Clear all
NCT03734627 2021-08-16

EndoGut

St. James's Hospital, Ireland

Completed
40 enrolled
Gastrointestinal

Feeding and Eating Disorders, Dumping Syndrome, Esophageal Neoplasms, Insulin Resistance, Nutrition Disorders, Gastroparesis

NCT02376478 2015-03-03

On the Impact of Therapeutic Tumor Necrosis Factor-alpha Inhibition on Anogenital Human Papillomavirus Infection

Medical University of Vienna

Completed
222 enrolled

Psoriasis, Inflammatory Bowel Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡